Mechanoregulation of Myofibroblast Fate and Cardiac Fibrosis

被引:13
|
作者
Kim, Peter [1 ]
Chu, Nick [1 ]
Davis, Jennifer [1 ,2 ,3 ]
Kim, Deok-Ho [1 ,2 ,4 ]
机构
[1] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA
[2] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA
[3] Univ Washington, Dept Pathol, Sch Med, Seattle, WA 98109 USA
[4] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
biomechanics; cardiac engineering; fibrosis; mechanoregulation; myofibroblasts; PROGENITOR-CELL FATE; SMOOTH-MUSCLE ACTIN; PRESSURE-OVERLOAD; MYOCARDIAL-INFARCTION; FIBROBLAST ACTIVATION; EXTRACELLULAR-MATRIX; LATENT TGF-BETA-1; TGF-BETA; MOLECULAR-MECHANISMS; CONTRACTILE ACTIVITY;
D O I
10.1002/adbi.201700172
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
During myocardial infarction, myocytes die and are replaced by a specialized fibrotic extracellular matrix, otherwise known as scarring. Fibrotic scarring presents a tremendous hemodynamic burden on the heart, as it creates a stiff substrate, which resists diastolic filling. Fibrotic mechanisms result in permanent scarring which often leads to hypertrophy, arrhythmias, and a rapid progression to failure. Despite the deep understanding of fibrosis in other tissues, acquired through previous investigations, the mechanisms of cardiac fibrosis remain unclear. Recent studies suggest that biochemical cues as well as mechanical cues regulate cells in myocardium. However, the steps in myofibroblast transdifferentiation, as well as the molecular mechanisms of such transdifferentiation in vivo, are poorly understood. This review is focused on defining myofibroblast physiology, scar mechanics, and examining current findings of myofibroblast regulation by mechanical stress, stiffness, and topography for understanding fibrotic disease dynamics.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The myofibroblast in pulmonary fibrosis
    Phan, SH
    CHEST, 2002, 122 (06) : 286S - 289S
  • [22] Cardiac fibrosis
    Frangogiannis, Nikolaos G.
    CARDIOVASCULAR RESEARCH, 2021, 117 (06) : 1450 - 1488
  • [23] Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
    Barnes, Jeffrey L.
    Gorin, Yves
    KIDNEY INTERNATIONAL, 2011, 79 (09) : 944 - 956
  • [24] Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis
    Gabasa, Marta
    Duch, Paula
    Jorba, Ignasi
    Gimenez, Alicia
    Lugo, Roberto
    Pavelescu, Irina
    Rodriguez-Pascual, Fernando
    Molina-Molina, Maria
    Xaubet, Antoni
    Pereda, Javier
    Alcaraz, Jordi
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28 (26) : 3741 - 3755
  • [25] Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation
    Yuan, Qian
    Tan, Roderick J.
    Liu, Youhua
    RENAL FIBROSIS: MECHANISMS AND THERAPIES, 2019, 1165 : 253 - 283
  • [26] The role of Smad signaling cascades in cardiac fibrosis
    Hanna, Anis
    Humeres, Claudio
    Frangogiannis, Nikolaos G.
    CELLULAR SIGNALLING, 2021, 77
  • [27] Myofibroblasts and inflammatory cells as players of cardiac fibrosis
    Kurose, Hitoshi
    Mangmool, Supachoke
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (08) : 1100 - 1113
  • [28] Hypoxia Suppresses TGF-B1-Induced Cardiac Myocyte Myofibroblast Transformation by Inhibiting Smad2/3 and Rhoa Signaling Pathways
    Yan, Zhankui
    Shen, Daifei
    Liao, Jilin
    Zhang, Yanmei
    Chen, Yicun
    Shi, Ganggang
    Gao, Fenfei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (01) : 250 - 257
  • [29] Human Antigen R, a Myofibroblast-Specific Target in Treating Cardiac Fibrosis
    Srivastava, Abhay
    Dhingra, Sanjiv
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2024, 9 (06): : 771 - 773
  • [30] c-Ski, Smurf2, and Arkadia as regulators of TGF-β signaling: new targets for managing myofibroblast function and cardiac fibrosis
    Cunnington, Ryan H.
    Nazari, Mansoreh
    Dixon, Ian M. C.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 87 (10) : 764 - 772